Clinical Trial Update: Integrin αvβ6-targeted PET in Malignant Tumors

View source ↗

Summary

A recruiting clinical trial evaluating an integrin αvβ6-targeted PET tracer for imaging malignant tumors, including non-small cell lung cancer and metastatic br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Integrin αvβ6-targeted PET tracer

Snippet

Sponsor: Zhongnan Hospital | Conditions: Malignant Neoplasm, PET/CT | Status: RECRUITING